Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants

Cancer

Volumn 78, Issue 4, 1996, Pages 741-744

  Patel, Shreyaskumar R ^a   Papadopoulos, Nicholas E ^a   Plager, Carl ^c   Linke, Kaye A ^a   Moseley, Stephen H ^b   Spirindonidis, C Harris ^b   Benjamin, Robert ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Department of Hematology Oncology   (United States)

^c Box 77 ^*

Author keywords

bone sarcomas; chemotherapy; osteosarcoma; paclitaxel(Taxol( ))

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CHONDROSARCOMA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG FEVER; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OSTEOSARCOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE NEOPLASMS; CHONDROSARCOMA; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA; PACLITAXEL;

EID: 0029766561     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960815)78:4<741::AID-CNCR8>3.0.CO;2-H     Document Type: Article

References (7)

1. Rowinsky EK, Donehower RC. Drug therapy: Paclitaxel (Taxol). N Engl J Med 1995;332(15):1004-14.
2. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10:1-10.
3. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA Cancer J Clin 1995;45:12.
4. Patel SR, Armen T, Carrasco CH, Raymond AK, Ayala AG, Murray JA, et al. Primary chemotherapy in malignant fibrous histiocytoma of bone - updated U.T.M.D./Anderson Cancer Center Experience. Cancer Treatment - An Update (Banzet P, Holland J, Khayat D, Weil M, Editors.) 1994;577-80.
5. Benjamin RS, Chu P, Patel SR, Raymond AK, Murray JA, Romsdahl MM, et al. Dedifferentiated Chondrosarcoma - A treatable disease. Proc Am Assoc Cancer Res 1995;36:243.
6. Jaffe N, Patel SR, Benjamin RS. Chemotherapy in Osteosarcoma - Basis for application and antagonism to implementation. Early controversies surrounding its implementation. Hematol Oncol Clin North Am 1995;9:825-40.
7. Balcerzak SP, Benedetti J, Weiss GR, Natale RB. A Phase II trial of Paclitaxel in patients with advanced soft-tissue sarcomas - A Southwest Oncology Group Study. Cancer 1995;76:2248-52.